Complementary Effects of Sirolimus-Eluting Stents and Glycoprotein Iib/Iiia Inhibitors for Percutaneous Coronary Intervention in Diabetic Patients: One-Year Follow up of a Single-Centre Registry
AuthID
P-004-J47
P-004-J47